Register now for the Heart Failure Policy Summit 2022

News & Events

26 August 2022
AUTHOR: HFPN Admin

 

We are delighted to announce the Heart Failure Policy Summit 2022!

Taking the form of four virtual sessions held in October and November, this year’s Summit will address how we can engage with policymakers and leaders to improve care for the millions of people living with heart failure across Europe.

Register now
 
 
With new clinical guidelines, evidence and innovation offering the hope of improving the lives of people with heart failure, now is the time to demand access to the best possible care for everyone living with the condition.

The 2022 Summit provides the opportunity for heart failure advocates to come together to focus on the essential topics that will define the future of heart failure care.

This year’s sessions will focus on the following topics:

 
We can’t wait to welcome you to the Heart Failure Policy Summit this autumn.
 

The HFPN has done a phenomenal job of setting the stage for success. Honestly, this is the benchmark for how a summit should be run.’

Marc Bains, Co-founder of the HeartLife Foundation, on the Heart Failure Policy Summit 2021

 

Register for the Heart Failure Policy Summit 2022

Tagged:

More from News & Events

9 things we learnt from the Heart Failure Policy Summit 2022
9 things we learnt from the Heart Failure Policy Summit 2022...
13 January 2023
Last year's Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points....
Read article
Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .